Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA176596
Max Phase: Preclinical
Molecular Formula: C12H26N2O
Molecular Weight: 214.35
Molecule Type: Small molecule
Associated Items:
ID: ALA176596
Max Phase: Preclinical
Molecular Formula: C12H26N2O
Molecular Weight: 214.35
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)CCCCCNCCCN(C)C
Standard InChI: InChI=1S/C12H26N2O/c1-12(15)8-5-4-6-9-13-10-7-11-14(2)3/h13H,4-11H2,1-3H3
Standard InChI Key: IDGXGMBKVHRAQC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 214.35 | Molecular Weight (Monoisotopic): 214.2045 | AlogP: 1.68 | #Rotatable Bonds: 10 |
Polar Surface Area: 32.34 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.34 | CX LogP: 1.11 | CX LogD: -2.17 |
Aromatic Rings: 0 | Heavy Atoms: 15 | QED Weighted: 0.56 | Np Likeness Score: -0.14 |
1. Dredar SA, Blankenship JW, Marchant PE, Manneh V, Fries DS.. (1989) Design and synthesis of inhibitors of N8-acetylspermidine deacetylase., 32 (5): [PMID:2709384] [10.1021/jm00125a010] |
Source(1):